Search results for Crmd

CorMedix (CRMD) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joseph TodiscoExecutive Vice President and Chief O...

CorMedix (CRMD) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joseph TodiscoExecutive Vice President and Chief O...

CorMedix: Long-Term Prospects Remain Poor Despite Q1 Beat

America's Car-Mart retains advisor to evaluate strategic alternatives

The Omnichannel Gap: Building the CRM of the Future for Patient Services

The Omnichannel Gap: Building the CRM of the Future for Patient Services Anonymous (not verified) Mon, 04/20/2026 - 08:10 pharmagather item url The Omnicha...

Revolution Medicines Rallies After Phase 3 Pancreatic Cancer Trial Doubles Survival Versus Chemo

Revolution Medicines stock rises after Phase 3 daraxonrasib data show survival gains in pancreatic cancer, with regulatory filings planned. Importance Rank: ...

Revolution Medicines

Revolution Medicines Anonymous (not verified) Tue, 05/05/2026 - 02:20 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...

Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...

CEL-SCI prices $7.2M offering at $1.20 per share

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK, April 30, 2026 /PRNewswire/ --

CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring

What You Should Know CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cance...

Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib

M&A: D2 Solutions Acquires ProModRx to Streamline Patient Journeys

What You Should Know The Acquisition: D2 Solutions, a healthcare consulting and technology company focused on market access, has officially acquired ProModRx, a cloud-based technol...

KORU Medical Systems, Inc. 2026 Q1 - Results - Earnings Call Presentation

Cellectar (CLRB) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DateThursday, May 14, 2026 at 8:30 a.m. ETCall participantsPresident and CEO — James CarusoChief Financial Officer — Chad KoleanChief Operating Offi...

JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT

JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT

Left Main Introduces New Cadence Experience, Expanding Multi-Channel Outreach in Salesforce

Left Main has launched a new Cadence experience within its Salesforce-native platform, designed to unify and streamline multi-channel outreach for real estate investment teams. The...

Credo Technology Group Holding Ltd (CRDO) DustPhotonics Ltd - M&A Call Transcript

Axtria acquires Conexus Solutions, enters into end-to-end CRM

Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry in Berkeley Heights, has acquired Conexus Solutions, a premier life sciences techno...

Recordati Rare Disease

Recordati Rare Disease Anonymous (not verified) Sat, 04/18/2026 - 08:08 field_thread_url https://cafepharma.com/boards/threads/recordati-rare-disease.68363...

Medical Care Technologies Inc. (OTC PINK:MDCE) Reaches #2 on InvestorsHub Breakout Board as Investor Attention Accelerat...